FABRIS, Marina
 Distribuzione geografica
Continente #
NA - Nord America 1.313
EU - Europa 353
AS - Asia 165
SA - Sud America 1
Totale 1.832
Nazione #
US - Stati Uniti d'America 1.310
CN - Cina 112
PL - Polonia 80
UA - Ucraina 67
DE - Germania 49
GB - Regno Unito 47
TR - Turchia 47
IT - Italia 44
SE - Svezia 28
FI - Finlandia 20
BE - Belgio 7
NL - Olanda 4
AT - Austria 3
CA - Canada 2
RU - Federazione Russa 2
VN - Vietnam 2
CO - Colombia 1
ES - Italia 1
FR - Francia 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
MX - Messico 1
MY - Malesia 1
Totale 1.832
Città #
Fairfield 176
Woodbridge 151
Chandler 119
Ashburn 111
Houston 101
Ann Arbor 94
Warsaw 80
Jacksonville 75
Seattle 73
Cambridge 56
Wilmington 53
Izmir 36
Beijing 29
New York 20
Nanjing 19
Princeton 19
Milan 16
Shanghai 16
Boardman 13
Bremen 13
Washington 13
Dearborn 12
San Diego 12
Tianjin 11
Brussels 7
Bologna 6
Changsha 6
Helsinki 6
Shenyang 6
Jiaxing 5
Nanchang 5
Norwalk 5
San Mateo 4
Auburn Hills 3
Des Moines 3
Falls Church 3
Ferrara 3
Hangzhou 3
London 3
Mountain View 3
Augusta 2
Borgo Val di Taro 2
Dong Ket 2
Gorle 2
Hebei 2
Jinan 2
Kilburn 2
Leawood 2
Monza 2
Redwood City 2
Vreden 2
Zhengzhou 2
Acton 1
Andover 1
Changchun 1
Chengdu 1
Ferrara di Monte Baldo 1
Granarolo 1
Groningen 1
Haikou 1
Hefei 1
Indiana 1
Irkutsk 1
Kuala Lumpur 1
Kunming 1
Lacco Ameno 1
Los Angeles 1
Medellín 1
Montreal 1
New Bedfont 1
Ningbo 1
Orange 1
Palm Bay 1
Philadelphia 1
Phoenix 1
Poggio Renatico 1
Prescot 1
Ravenna 1
Rueil-Malmaison 1
Southwark 1
The Bronx 1
Toronto 1
Veracruz 1
Verona 1
Totale 1.445
Nome #
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 187
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 135
null 131
Exon skipping-mediated dystrophin reading frame restoration for small mutations 130
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 119
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 117
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 111
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 109
Transcriptional behavior of DMD gene duplications in DMD/BMD males 105
GENETIC, CLINICAL AND NEUROPATHOLOGICAL INSIGHTS INTO PATIENTS WITH ASCERTAINED DIAGNOSIS OF HUNTINGTON DISEASE 105
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 103
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 100
null 91
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 83
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 82
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 43
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 41
Inhibition of HIV-1 tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity 22
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 16
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 15
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 12
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 11
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 11
Totale 1.879
Categoria #
all - tutte 7.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019203 0 0 0 0 0 0 0 0 0 37 63 103
2019/2020449 55 26 17 58 31 50 40 48 38 58 18 10
2020/2021266 24 23 9 49 13 19 16 24 10 29 37 13
2021/2022229 5 14 26 5 7 7 17 11 8 12 35 82
2022/2023297 23 33 1 34 76 31 15 23 30 9 15 7
2023/2024171 10 23 27 6 21 53 6 23 1 1 0 0
Totale 1.879